NAGENiagen Bioscience Inc

$391M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+7.2% YoY

Gross Profit

$2M30.5% margin

Operating Income

-$8M-96.9% margin

Net Income

-$8M-97.3% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$6M

Total Liabilities

$4M

Stockholders' Equity

$3M

Cash & Equivalents

$420,152

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+7.2%
Gross Profit	$2M	$3M	-16.1%
Operating Income	-$8M	-$2M	-289.9%
Net Income	-$8M	-$2M	-284.8%

NAGE FY 2011 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena